Cash flow Dai-ichi Life Holdings, Inc.

Equities

8750

JP3476480003

Life & Health Insurance

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-05 EST			5-day change	1st Jan Change
1,221.00 ^JPY	+0.12%		+0.21%	+15.32%

12-04	Dai-ichi Life Holdings, Inc., Q2 2026 Earnings Call, Nov 27, 2025
11-19	Dai-ichi Life Holdings, Inc., Q2 2026 Earnings Call, Nov 14, 2025

c063a3d87f2166669a1b4bcefad.OhNCTlJ7xsLztZEbyMzgTfGNE6Vp2Y_aKOtks4M7Kmg.fiMBNBculvWcwfdEr_mLJr7jIfYclempeYId2-RdaCRvJTs4BgGWpsbz3A

Published financial data: DAI-ICHI LIFE HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	4,730B	5,292B	6,635B	7,526B	6,796B
Total Interest And Dividend Income	1,303B	1,348B	1,362B	1,364B	1,527B
Gain (Loss) on Sale of Investments, Total (Rev)	777B	697B	591B	1,057B	429B
Other Revenues, Total	378B	367B	630B	468B	549B
Total Revenues	7,189B	7,704B	9,219B	10,416B	9,301B
Policy Benefits	6,050B	6,260B	6,638B	8,722B	7,096B
Depreciation & Amortization - (IS) - (Collected)	13.19B	13.46B	13.68B	14.04B	14.26B
Selling General & Admin Expenses, Total	689B	752B	831B	926B	990B
Provision for Bad Debts	-	-	-	5.1B	-
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	-17.59B	-459M	-1.51B	-4.39B	-1.78B
Other Operating Expenses	355B	313B	588B	325B	404B
Total Operating Expenses	7,125B	7,339B	8,072B	9,996B	8,506B
Operating Income	63.91B	365B	1,147B	420B	795B
Interest Expense, Total	-33.48B	-26.7B	-33B	-39.68B	-49.31B
Currency Exchange Gains (Loss)	445B	453B	227B	539B	-127B
Other Non Operating Income (Expenses)	-4M	-40.18B	-1M	-99.26B	-4M
EBT, Excl. Unusual Items	475B	751B	1,341B	820B	619B
Gain (Loss) on Sale of Investments	-	-247B	-1,025B	-368B	-
Gain (Loss) on Sale of Assets	33.57B	-2.56B	-1.01B	20M	-7.05B
Asset Writedown	-2.55B	-3.85B	-15.94B	-5.31B	-2.24B
Other Unusual Items	-23.84B	-22.61B	-18.27B	-19.22B	-47.48B
EBT, Incl. Unusual Items	483B	474B	281B	427B	562B
Income Tax Expense	119B	65.02B	88.38B	106B	133B
Earnings From Continuing Operations	364B	409B	192B	321B	430B
Net Income to Company	364B	409B	192B	321B	430B
Minority Interest	-	-	-	-21M	-
Net Income - (IS)	364B	409B	192B	321B	430B
Net Income to Common Incl Extra Items	364B	409B	192B	321B	430B
Net Income to Common Excl. Extra Items	364B	409B	192B	321B	430B
Per Share Items
Net EPS - Basic	81.4	95.79	47.32	82.42	115.95
Basic EPS - Continuing Operations	81.4	95.79	47.32	82.42	115.95
Basic Weighted Average Shares Outstanding	4.47B	4.27B	4.06B	3.89B	3.71B
Net EPS - Diluted	81.35	95.74	47.3	82.4	115.93
Diluted EPS - Continuing Operations	81.35	95.74	47.3	82.4	115.93
Diluted Weighted Average Shares Outstanding	4.47B	4.28B	4.07B	3.89B	3.71B
Normalized Basic EPS	66.48	109.82	206.2	131.63	104.42
Normalized Diluted EPS	66.44	109.76	206.13	131.59	104.41
Dividend Per Share	15.5	20.75	21.5	28.25	34.25
Payout Ratio	19.2	16.78	44.1	26.28	37.79
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	137B	455B	1,254B	519B	927B
EBITA	67.95B	370B	1,154B	429B	820B
EBIT	63.91B	365B	1,147B	420B	795B
Total Revenues (As Reported)	7,828B	-	-	-	9,873B
Effective Tax Rate - (Ratio)	24.61	13.71	31.49	24.87	23.6
Total Current Taxes	116B	-	-	-	125B
Total Deferred Taxes	2.62B	-	-	-	7.93B
Normalized Net Income	297B	469B	838B	512B	387B
Non-Cash Pension Expense	5.87B	4.09B	8.85B	-8.01B	-
Supplemental Operating Expense Items
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Total Other Investments	51,131B	51,504B	46,711B	51,839B	53,241B
Total investments	51,131B	51,504B	46,711B	51,839B	53,241B
Cash And Equivalents	2,288B	2,184B	1,619B	2,064B	2,456B
Reinsurance Recoverable - (IS)	1,669B	1,925B	1,659B	1,853B	2,048B
Other Receivables - (Insurance Template)	3,734B	4,714B	5,563B	5,665B	5,111B
Gross Property Plant And Equipment	1,747B	-	-	-	1,852B
Accumulated Depreciation	-633B	-	-	-	-579B
Net Property Plant And Equipment	1,113B	1,160B	1,240B	1,224B	1,273B
Goodwill	42.7B	56.24B	120B	115B	328B
Other Intangibles, Total	402B	447B	642B	593B	779B
Restricted Cash	1,131B	1,107B	911B	889B	899B
Deferred Tax Assets Long-Term (Collected)	12.01B	9.38B	248B	179B	171B
Other Long-Term Assets, Total	2,070B	2,775B	2,866B	3,118B	3,287B
Total Assets	63,594B	65,881B	61,579B	67,540B	69,593B
Liabilities
Insurance And Annuity Liabilities	50,298B	51,821B	52,930B	55,692B	58,134B
Unpaid Claims	754B	925B	1,017B	1,461B	1,434B
Reinsurance Payable - (BS)	797B	895B	598B	476B	302B
Current Portion of Long-Term Debt	266B	21.91B	8.07B	17.54B	-
Current Portion of Leases	2.88B	-	-	-	-
Short-Term Borrowings	2,367B	31.63B	43.06B	53.09B	1,741B
Long-Term Debt	1,705B	1,562B	1,556B	1,767B	1,153B
Long-Term Leases	6.55B	-	-	-	-
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	52.86B	-	-	-	11.19B
Pension & Other Post Retirement Benefits	420B	393B	369B	213B	159B
Deferred Tax Liability Non-Current	630B	327B	115B	328B	168B
Other Non Current Liabilities	1,488B	5,496B	2,071B	3,651B	3,023B
Total Liabilities	58,787B	61,473B	58,706B	63,658B	66,123B
Common Stock, Total	344B	344B	344B	344B	344B
Additional Paid In Capital	330B	330B	330B	331B	331B
Retained Earnings	1,376B	1,335B	1,310B	1,215B	1,350B
Treasury Stock	-156B	-12.72B	-13.92B	-17.26B	-9.94B
Comprehensive Income and Other	2,913B	2,412B	903B	2,010B	1,455B
Total Common Equity	4,807B	4,409B	2,873B	3,882B	3,470B
Minority Interest	-	-	1M	-	-
Total Equity	4,807B	4,409B	2,873B	3,882B	3,470B
Total Liabilities And Equity	63,594B	65,881B	61,579B	67,540B	69,593B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.44B	4.1B	3.93B	3.78B	3.68B
ECS Total Common Shares Outstanding	4.44B	4.1B	3.93B	3.78B	3.68B
Book Value / Share	1.08K	1.08K	730.56	1.03K	942.59
Tangible Book Value	4,362B	3,906B	2,111B	3,174B	2,362B
Tangible Book Value Per Share	982.23	953.11	536.88	839.47	641.79
Total Debt	4,347B	1,615B	1,607B	1,838B	2,894B
Net Debt	2,060B	-569B	-11.66B	-227B	438B
Debt Equivalent of Unfunded Proj. Benefit Obligation	419B	393B	368B	212B	-
Minority Interest, Total (Incl. Fin. Div)	-	-	1M	-	-
Account Code - Inventory Valuation	3	-	-	-	3
Land - (BS)	762B	-	-	-	881B
Full Time Employees	64.82K	62.26K	61K	59.5K	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	364B	474B	281B	427B	430B
Depreciation, Depletion & Amortization	69.27B	84.81B	100B	89.44B	107B
Amortization of Goodwill and Intangible Assets - (CF)	4.04B	5.15B	7.03B	9.62B	25.23B
Total Depreciation, Depletion & Amortization	73.31B	89.96B	107B	99.06B	132B
(Gain) Loss On Sale of Asset - (CF)	-33.87B	6.04B	16.44B	4.38B	1.1B
(Gain) Loss on Sale of Investments - (CF)	-749B	-451B	432B	-669B	-431B
Total Asset Writedown	2.55B	-	-	-	2.24B
Provision for Credit Losses	369M	-	-	-	6.56B
(Income) Loss On Equity Investments - (CF)	-10.64B	-5.53B	-6.18B	-9.53B	-3.53B
Reinsurance Recoverable - (CF)	-213B	-	-	-	5.25B
Reinsurance Payable - (CF)	-55.66B	-	-	-	-193B
Change in insurance Reserves / Liabilities	924B	410B	-675B	1,713B	550B
Change in Other Net Operating Assets (Collected)	163B	-86.81B	438B	153B	-320B
Other Operating Activities	-544B	-899B	-725B	-721B	413B
Cash from Operations	-79.9B	-462B	-132B	997B	593B
Capital Expenditure	-38.17B	-99.46B	-118B	-51.14B	-60.12B
Sale of Property, Plant, and Equipment	23.28B	31.91B	56.55B	38.78B	47.01B
Cash Acquisitions	-16.8B	-	-	-	-234B
Divestitures	-	-	-	-	-
Purchase / Sale of Intangible Assets	-38.31B	-48.85B	-43.82B	-38.69B	-44.35B
Investment in Marketable and Equity Securities, Total	802B	474B	3,355B	-1,508B	-443B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-112B	-76.92B	-158B	-221B	-215B
Other Investing Activities, Total	-67.97B	682B	-2,781B	1,178B	-31.84B
Cash from Investing	551B	963B	310B	-602B	-980B
Short Term Debt Issued, Total	17.28B	110B	-	-	-
Long-Term Debt Issued, Total	336B	111B	-	191B	316B
Total Debt Issued	354B	221B	-	191B	316B
Short Term Debt Repaid, Total	-	-	-13.6B	-129B	-813M
Long-Term Debt Repaid, Total	-188B	-130B	-102B	-	-125B
Total Debt Repaid	-188B	-130B	-116B	-129B	-125B
Issuance of Common Stock	-	-	147M	-	-
Repurchase of Common Stock	-30B	-200B	-120B	-120B	-102B
Common Dividends Paid	-69.86B	-68.68B	-84.81B	-84.31B	-162B
Common & Preferred Stock Dividends Paid	-69.86B	-68.68B	-84.81B	-84.31B	-162B
Other Financing Activities, Total	-501M	-3.42B	-5.22B	-3.87B	-203M
Cash from Financing	65.59B	-181B	-325B	-146B	-73.57B
Foreign Exchange Rate Adjustments	28.28B	33.34B	48.02B	5.12B	2.61B
Miscellaneous Cash Flow Adjustments	-	-1M	1M	-	1M
Net Change in Cash	565B	354B	-99.46B	255B	-459B
Supplemental Items
Cash Interest Paid	43.39B	32.08B	36.07B	42.71B	49.72B
Cash Income Tax Paid (Refund)	44.5B	141B	155B	-6.86B	102B
Net Debt Issued / Repaid	166B	91.39B	-116B	62.42B	191B
Levered Free Cash Flow	-20.93B	-106B	917B	359B	147B
Unlevered Free Cash Flow	-7.75M	-89.09B	938B	384B	178B
Change In Net Working Capital	36.79B	259B	-275B	-112B	346B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.06	0.35	1.12	0.41	0.72
Return on Total Capital	0.5	3	13.65	5.14	7.9
Return On Equity %	8.48	8.88	5.28	9.5	11.69
Return on Common Equity	8.48	8.88	5.28	9.5	11.69
Margin Analysis
Gross Profit Margin %	15.6	18.73	27.99	16.22	23.69
SG&A Margin	9.59	9.76	9.02	8.89	10.64
EBITDA Margin %	1.91	5.9	13.6	4.98	9.97
EBITA Margin %	0.95	4.8	12.51	4.12	8.82
EBIT Margin %	0.89	4.73	12.44	4.03	8.55
Income From Continuing Operations Margin %	5.06	5.31	2.09	3.08	4.62
Net Income Margin %	5.06	5.31	2.09	3.08	4.62
Net Avail. For Common Margin %	5.06	5.31	2.09	3.08	4.62
Normalized Net Income Margin	4.13	6.09	9.09	4.92	4.16
Levered Free Cash Flow Margin	-0.29	-1.37	9.95	3.45	1.58
Unlevered Free Cash Flow Margin	-0	-1.16	10.17	3.68	1.91
Asset Turnover
Asset Turnover	0.12	0.12	0.14	0.16	0.14
Fixed Assets Turnover	6.42	6.78	7.68	8.45	7.45
Short Term Liquidity
Current Ratio	1.1	2.39	2.12	2.09	1.38
Quick Ratio	0.49	1.07	0.89	0.97	0.63
Operating Cash Flow to Current Liabilities	-0.02	-0.2	-0.06	0.41	0.15
Average Days Payable Outstanding	111.53	121.99	117.42	92.23	116.43
Long Term Solvency
Total Debt/Equity	90.44	36.64	55.95	47.34	83.41
Total Debt / Total Capital	47.49	26.82	35.88	32.13	45.48
LT Debt/Equity	35.61	35.43	54.17	45.52	33.23
Long-Term Debt / Total Capital	18.7	25.93	34.73	30.89	18.12
Total Liabilities / Total Assets	92.44	93.31	95.33	94.25	95.01
EBIT / Interest Expense	1.91	13.66	34.75	10.57	16.12
EBITDA / Interest Expense	4.1	17.03	38	13.07	18.8
(EBITDA - Capex) / Interest Expense	2.96	13.3	34.43	11.78	17.58
Total Debt / EBITDA	31.68	3.55	1.28	3.54	3.12
Net Debt / EBITDA	15.01	-1.25	-0.01	-0.44	0.47
Total Debt / (EBITDA - Capex)	43.89	4.55	1.41	3.93	3.34
Net Debt / (EBITDA - Capex)	20.79	-1.6	-0.01	-0.49	0.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.7	7.17	19.67	12.98	-7.43
Gross Profit, 1 Yr. Growth %	-35.85	28.74	78.76	-34.51	67.36
EBITDA, 1 Yr. Growth %	-81.35	231.33	175.78	-58.64	1.71K
EBITA, 1 Yr. Growth %	-89.93	444.3	211.93	-62.8	-2.24K
EBIT, 1 Yr. Growth %	-90.48	470.63	214.41	-63.42	-1.76K
Earnings From Cont. Operations, 1 Yr. Growth %	1.02K	12.53	-53.02	66.81	33.93
Net Income, 1 Yr. Growth %	1.02K	12.53	-53.02	66.8	33.93
Normalized Net Income, 1 Yr. Growth %	249.84	57.96	78.56	-38.87	37.12
Diluted EPS Before Extra, 1 Yr. Growth %	1.04K	17.69	-50.59	74.2	40.69
Net Property, Plant and Equip., 1 Yr. Growth %	-1.15	4.17	6.92	-1.25	3.98
Total Assets, 1 Yr. Growth %	5.97	3.6	-6.53	9.68	3.04
Common Equity, 1 Yr. Growth %	27.28	-8.29	-34.83	35.12	-10.62
Tangible Book Value, 1 Yr. Growth %	32.02	-10.46	-45.94	50.31	-25.56
Cash From Operations, 1 Yr. Growth %	-113.54	478.29	-71.33	-852.92	-40.59
Capital Expenditures, 1 Yr. Growth %	-12.23	160.61	18.49	-56.61	17.55
Levered Free Cash Flow, 1 Yr. Growth %	-98.02	405.41	-966.91	-60.87	-
Unlevered Free Cash Flow, 1 Yr. Growth %	-100	1.15M	-1.15K	-59.08	-
Dividend Per Share, 1 Yr. Growth %	0	33.87	3.61	31.4	21.24
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.05	5.93	13.25	16.28	-
Gross Profit, 2 Yr. CAGR %	-18	-9.12	51.7	8.2	-
EBITDA, 2 Yr. CAGR %	-52.94	-21.38	202.28	6.8	-
EBITA, 2 Yr. CAGR %	-65.02	-25.96	312.05	7.71	-
EBIT, 2 Yr. CAGR %	-65.94	-26.29	323.57	7.25	-
Earnings From Cont. Operations, 2 Yr. CAGR %	27.14	255.27	-27.29	-11.48	-
Net Income, 2 Yr. CAGR %	27.14	255.27	-27.29	-11.48	-
Normalized Net Income, 2 Yr. CAGR %	17.31	135.08	67.94	4.48	-
Diluted EPS Before Extra, 2 Yr. CAGR %	29.42	266.5	-23.75	-7.23	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.41	1.48	5.54	2.75	-
Total Assets, 2 Yr. CAGR %	6.62	4.78	-1.6	1.25	-
Common Equity, 2 Yr. CAGR %	13.77	8.04	-22.69	-6.16	-
Tangible Book Value, 2 Yr. CAGR %	15.52	8.73	-30.43	-9.86	-
Cash From Operations, 2 Yr. CAGR %	-78.3	-11.51	28.76	46.92	-
Capital Expenditures, 2 Yr. CAGR %	-18.99	51.24	75.73	-28.3	-
Levered Free Cash Flow, 2 Yr. CAGR %	-75.25	-68.36	561.92	84.19	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	-99.54	-70.58	34.68K	107.52	-
Dividend Per Share, 2 Yr. CAGR %	3.39	15.7	17.78	16.68	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.52	3.73	10.32	13.16	-
Gross Profit, 3 Yr. CAGR %	-13.98	-4.69	13.87	14.65	-
EBITDA, 3 Yr. CAGR %	-42.62	-9.81	19.46	55.76	-
EBITA, 3 Yr. CAGR %	-53.36	-12.68	19.58	84.84	-
EBIT, 3 Yr. CAGR %	-54.22	-12.86	19.54	87.23	-
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.01	22.07	80.99	-4.11	-
Net Income, 3 Yr. CAGR %	-0.01	22.07	80.99	-4.11	-
Normalized Net Income, 3 Yr. CAGR %	8.03	29.54	114.49	19.91	-
Diluted EPS Before Extra, 3 Yr. CAGR %	1.58	25.38	87.92	0.43	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.51	0.42	3.26	3.22	-
Total Assets, 3 Yr. CAGR %	5.86	5.6	0.86	2.03	-
Common Equity, 3 Yr. CAGR %	8.64	5.88	-8.71	-6.88	-
Tangible Book Value, 3 Yr. CAGR %	9.37	6.11	-13.86	-10.06	-
Cash From Operations, 3 Yr. CAGR %	-59.11	-35.18	-39.22	131.97	-
Capital Expenditures, 3 Yr. CAGR %	2.4	19.58	39.43	10.24	-
Levered Free Cash Flow, 3 Yr. CAGR %	-49.57	-32.36	-4.62	157.86	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-96.58	-37.72	-3.06	3.57K	-
Dividend Per Share, 3 Yr. CAGR %	7.43	12.69	11.52	22.15	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.28	4.19	6.06	8.58	6.26
Gross Profit, 5 Yr. CAGR %	-7.58	-1.45	7.93	0.27	4.74
EBITDA, 5 Yr. CAGR %	-25.5	-2.83	11.54	-3.5	4.73
EBITA, 5 Yr. CAGR %	-33.79	-4.21	11.48	-5.03	3.98
EBIT, 5 Yr. CAGR %	-34.51	-4.32	11.48	-5.31	3.44
Earnings From Cont. Operations, 5 Yr. CAGR %	15.3	12.1	-11.98	7.35	67.66
Net Income, 5 Yr. CAGR %	15.3	12.1	-11.98	7.35	67.66
Normalized Net Income, 5 Yr. CAGR %	8.19	17.15	28.89	18.86	35.43
Diluted EPS Before Extra, 5 Yr. CAGR %	16.68	14.28	-9.43	11.15	74.68
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.14	0.37	1.86	1.35	2.48
Total Assets, 5 Yr. CAGR %	4.96	4.85	2.81	3.84	3.01
Common Equity, 5 Yr. CAGR %	10.39	7.04	-5.18	0.89	-1.68
Tangible Book Value, 5 Yr. CAGR %	11.55	7.63	-8.73	-0.59	-6.49
Cash From Operations, 5 Yr. CAGR %	-47.55	-19.62	-35.31	-10.08	0.08
Capital Expenditures, 5 Yr. CAGR %	11.6	20.11	27.09	-2.54	6.69
Levered Free Cash Flow, 5 Yr. CAGR %	-44.43	-6.95	41.23	0.98	-32.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	-88.75	-12.85	37.52	0.79	-29.59
Dividend Per Share, 5 Yr. CAGR %	12.12	14.06	11.46	14.27	17.18